CN109157548A - It is a kind of with antifatigue and Yang strengthening function composition and preparation method - Google Patents
It is a kind of with antifatigue and Yang strengthening function composition and preparation method Download PDFInfo
- Publication number
- CN109157548A CN109157548A CN201811167554.5A CN201811167554A CN109157548A CN 109157548 A CN109157548 A CN 109157548A CN 201811167554 A CN201811167554 A CN 201811167554A CN 109157548 A CN109157548 A CN 109157548A
- Authority
- CN
- China
- Prior art keywords
- antifatigue
- composition
- powder
- yang
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 51
- 238000005728 strengthening Methods 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 55
- 235000005638 Austrian pine Nutrition 0.000 claims abstract description 33
- 235000008565 Pinus banksiana Nutrition 0.000 claims abstract description 33
- 235000013264 Pinus jeffreyi Nutrition 0.000 claims abstract description 33
- 235000008578 Pinus strobus Nutrition 0.000 claims abstract description 33
- 235000008585 Pinus thunbergii Nutrition 0.000 claims abstract description 33
- 235000014030 Podocarpus spicatus Nutrition 0.000 claims abstract description 33
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 claims abstract description 33
- 241000894006 Bacteria Species 0.000 claims abstract description 31
- 244000019397 Pinus jeffreyi Species 0.000 claims abstract description 30
- 241000233866 Fungi Species 0.000 claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000002775 capsule Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 229940100688 oral solution Drugs 0.000 claims description 2
- -1 oral solution Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000282376 Panthera tigris Species 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 35
- 230000006870 function Effects 0.000 abstract description 32
- 230000003078 antioxidant effect Effects 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 12
- 239000003963 antioxidant agent Substances 0.000 abstract description 11
- 235000006708 antioxidants Nutrition 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 9
- 241000569924 Pinanga maculata Species 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 49
- 241000699666 Mus <mouse, genus> Species 0.000 description 46
- 210000002966 serum Anatomy 0.000 description 25
- 230000009182 swimming Effects 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 20
- 229920002527 Glycogen Polymers 0.000 description 18
- 229940096919 glycogen Drugs 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 210000003205 muscle Anatomy 0.000 description 14
- 239000013641 positive control Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 239000002253 acid Substances 0.000 description 12
- 238000012546 transfer Methods 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 230000033001 locomotion Effects 0.000 description 11
- 102100026189 Beta-galactosidase Human genes 0.000 description 10
- 108010059881 Lactase Proteins 0.000 description 10
- 108010005774 beta-Galactosidase Proteins 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 229940116108 lactase Drugs 0.000 description 10
- 239000004310 lactic acid Substances 0.000 description 10
- 235000014655 lactic acid Nutrition 0.000 description 10
- 238000011049 filling Methods 0.000 description 9
- 102000019197 Superoxide Dismutase Human genes 0.000 description 8
- 108010012715 Superoxide dismutase Proteins 0.000 description 8
- 239000000902 placebo Substances 0.000 description 8
- 229940068196 placebo Drugs 0.000 description 8
- 238000010171 animal model Methods 0.000 description 7
- 230000002440 hepatic effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 5
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 5
- 230000002567 autonomic effect Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 229940116269 uric acid Drugs 0.000 description 5
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- 244000251141 Podocarpus spicatus Species 0.000 description 3
- 244000223977 Tuber melanosporum Species 0.000 description 3
- 235000002777 Tuber melanosporum Nutrition 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003163 gonadal steroid hormone Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 241000577937 Sarcodon imbricatus Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000409065 Albatrellus dispansus Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 231100000416 LDH assay Toxicity 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 231100000991 Reactive Oxygen Species (ROS) Photosafety Assay Toxicity 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 240000003186 Stachytarpheta cayennensis Species 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 108010036302 hemoglobin AS Proteins 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002843 lactate dehydrogenase assay Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides a kind of with antifatigue and Yang strengthening function composition and preparation method, is made of HEIHUZHANG fungus powder, black pine bacterium powder；The composition have improve exercise tolerance, relieve fatigue, anti-oxidant and tonifying kidney and strengthening yang the effect of, confirm that there are good antifatigue and yang invigorating functions through zoopery and clinical practice.The present invention combines theory according to Chinese medicine compatibility theory and traditional Chinese and western medicine and is configured to compound preparation, and using the black tiger palm and black pine as primary raw material, the two collaboration plays significant function assessment activity, and greatly reduces cost of material, is conducive to industrialized production.
Description
Technical field
The invention belongs to health care product processing technique fields, and in particular to a kind of with antifatigue and Yang strengthening function composition
And preparation method and application.
Background technique
With the increasingly quickening of social development, scientific and technological progress and rhythm of life, the pressure that people are born is being gradually increased,
The mental and manual labor of high-intensitive high load capacity make most of worker be chronically at fatigue or sub-health state, as colourless without
Power insomnia and dreamful sleep, is had a pain in the back, lather, memory loss, positive fistula premature ejaculation, it is prematurely senile phenomena such as.China or even full generation
Boundary has every year causes dead case because of long-time over fatigue.It is investigated according to WHO, the whole world has 35% or more people to be in tired
Labor state, if cannot eliminate in time after fatigue generation, gradually accumulation will appear overtraining syndrome (OTS) or chronic
The illnesss such as fatigue syndrome (CFS), while endocrine disturbance, immunity degradation occurs with body, or even occur organic
Lesion becomes an important factor for threatening human physical and mental health.Fatigue is damaged caused by muscle and bone organ being capable of direct shadow
The performance of skeletal muscle is rung, myocardial blood supply is blocked.Under work on hand environment and the unalterable situation of pressure, then fatigue is needed
Worker has the health food of anti-fatigue effect to alleviate and restore organism fatigue according to own situation timely and appropriate discovery supplement, mentions
High body anti-pressure ability.The mechanism of fatigue mainly includes (1) energy substance exhaustion hypothesis (2) metabolite Heaping doctrine
(3) interior environmental stability imbalance theory (4) protectiveness inhibits theory (5) endocrine system dissonance theory (6) catastrophe theory (7) certainly
It is influenced by base theoretical；Wherein, free radical theory increasingly obtains the approval of researcher, and a large amount of report display movements can induce a large amount of
The generation of free radical.Lead to blood lactase acid in Mice Body, blood urea nitrogen and hemoglobin as wang et al. discovery power exhausts swimming test
Content decline, it is believed that may be that function caused by the oxidative stress that movement generates declines；Nazeer et al. research discovery white flower fish
Protein enzymatic hydrolyzate has anti peroxidation of lipid ability and improves the vigor of antioxidase system, and it is anti-may to alleviate oxidative stress with it
Should be related to enhance tolerance of exercise, this also from certain angle reflect between antioxidant activity and antifatigue effect there is
Correlation.Therefore, how research is by preventing the generation of free radical from improving body movement endurance, to play tonifying kidney and strengthening yang
Effect is particularly important.
In recent years, on folk medicine and modern science experiment basis, many scholars are seeking antifatigue and Yang invigorating medicine
Aspect has done a large amount of work, and all there is many side effects and adverse reaction such as physical strength are excessively saturating for this kind of primary treatment drug
Branch, while drug cost is also high.Chinese traditional herbs become in recent years because of few side effects, without the excitant ingredient being harmful to the human body
The research hotspot for carrying out anti-fatigue medicament, due to " Diet cures more than the doctors ", the ideas such as " there's no such thing as a totally safe medicine " are rooted in the hearts of the people, and cause to resist tired
Labor functional health care food is more welcomed by the people compared with anti-fatigue medicament, therefore finds effective exploitation, safety and Small side effects
Functional food becomes a kind of very promising solution route.
Currently, the effect of Chinese medicine class anti-fatigue product is mainly relieved fatigue by following mechanism realization:
1, energy is supplemented, is reached by the trophic factors of supplement body consumption and is maintained body normal physiological function, relieves fatigue
Purpose such as increases glycogen storage level.
2, the intake of vitamin and microelement needed by human is supplemented.
3, the removing and discharge of acceleration bodies intracellular metabolite substance, reaches antifatigue purpose.
4, sex hormone level is adjusted, such as testosterone, progesterone, estradiol and cortisol equal size.
5, excessive free free radical is removed, antioxidant ability of organism is improved.
Existing anti-fatigue health-product containing in the market, kind is more, and function and effect are different, and quality is also irregular.According to
Known to applicant, general anti-fatigue medicament accelerates the clearance rate of metabolite, adjusts micro-loop by providing energy for body
Border, improves immunity or directly stimulation nervous system reaches antifatigue effect.Although this kind of drugs for nervous is very effective in cure,
But very big to the harm of cardiovascular and cerebrovascular and nervous system, there are certain risk, curative effect is up for further verifying.
HEIHUZHANG fungus scientific name jujube Sarcodon imbricatus (L. Ex Franch.) Karst (Sarcodon imbricatus(L.ex Fr.) Karst.), it is subordinate to
In Basidiomycetes Polyporus, it is the exclusive rare wild mushrooms in the area Yunnan Qian Zang, is rich in polysaccharide abundant, protein, amino
Acid, crude fibre, phenolic compound and several mineral materials microelement have very high tonic value and pharmacological activity.Motherland
Medicine thinks that HEIHUZHANG fungus is sweet natured, has the effect of relaxing tendons and activating collaterals, while can reduce cholesterol, QI invigorating tonifying Qi, Chinese medicine Zhuifengsan
It trembles with fear, controls wind blood-breaking, stomach function regulating defaecation, blood pressure lowering, the poison of solution food, controls the effects of headache and dizziness.However, at present to HEIHUZHANG fungus
Research primarily focuses on chemical composition analysis, Polyose extraction, the optimization of strain liquid fermentation culture conditions, In Vitro Bacteriostasis and resists in vivo
The research of tumor promotion, about HEIHUZHANG fungus it is antifatigue with it is anti-oxidant in terms of have not been reported, lack to its system comprehensively
Understanding.
Black pine be also known as ferfas (Tuber melanosporum) it is a kind of rare very your wild edible for being grown on underground
Fungi has high healthy nutritive value.Due to its growth conditions harshness, annual worldwide production is very rare, therefore price
Fairly expensive, comparable to gold, referred to as on dining table " Black Diamond ".It is domestic at present still few for the research of black pine, mainly
Be the Study on Physiological Activity of black pine polysaccharide is also only rested on anti-oxidant about kind classification and resource distribution etc., and its
He is rarely reported activity.Numerous studies prove that black pine contains 18 kinds of amino acid (required amino that cannot be synthesized including human body
Acid), protein abundant, vitamin, unsaturated fatty acid and mineral trace element, the mankind eat black pine existing more than 2000
Year history, in addition to playing an important role in delicious food other than, currently on the market one after another release with black pine for mainly at
The product divided, such as chocolate, bread, drink, pressed candy, facial mask etc..
So far, it is not yet found that closing with HEIHUZHANG fungus, black pine bacterium single component or by HEIHUZHANG fungus and black pine
The mutual compatibility of bacterium obtains the pertinent literature of ideal treatment with its synergistic effect for antifatigue, anti-oxidant and tonifying kidney and strengthening yang
Report.Therefore, it develops a kind of while there is antifatigue, anti-oxidant and tonifying kidney and strengthening yang effect functional health-care food to have well
Market prospects, composition provided by the invention have irreplaceable advantage and huge potentiality to be exploited.
Summary of the invention
The invention discloses a kind of with antifatigue and Yang strengthening function composition, improve exercise tolerance, relieve fatigue,
There is the effect of obvious in terms of anti-oxidant and tonifying kidney and strengthening yang.
The present invention further discloses a kind of preparation methods with antifatigue and Yang strengthening function composition, are suitable for work
Industry metaplasia produces.
The present invention provides a kind of with antifatigue and Yang strengthening function composition, by the raw material group of following parts by weight
At: 30-85 parts of HEIHUZHANG fungus powder, 25-55 parts of black pine bacterium powder.
Preferably, described a kind of with antifatigue and Yang strengthening function composition, it is composed of the following raw materials in parts by weight:
45-65 parts of HEIHUZHANG fungus powder, 35-45 parts of black pine bacterium powder.
It is furthermore preferred that it is described a kind of with antifatigue and Yang strengthening function composition, by the raw material group of following parts by weight
At: 60 parts of HEIHUZHANG fungus powder, 40 parts of black pine bacterium powder.
The present invention provides a kind of preparation methods with antifatigue and Yang strengthening function composition, by following steps
It is prepared:
(1) above-mentioned raw materials are weighed in proportion, are added water to cook 1-3 times, and 1-3 hours each, the quality that water is added every time is composition
8-12 times of quality, obtains decoction liquor；
(2) decoction liquor is merged, filter, after reduced pressure, it is spray-dried at powder to get.
The present invention also provides described a kind of antifatigue and establishing-Yang is being prepared with antifatigue and Yang strengthening function composition
Purposes in preparation.
Described antifatigue and yang-invigorating formulation can be powder, oral solution, granule, tablet, capsule, pill, syrup
Or paste etc..
Pharmaceutically acceptable customary adjuvant can also be added in of the present invention antifatigue and yang-invigorating formulation.
The invention has the advantages that；
It is a kind of with antifatigue and Yang strengthening function combination it is an object of the invention to provide in place of overcome the deficiencies in the prior art
Object, preparation method and application, the composition have improve exercise tolerance, relieve fatigue, anti-oxidant and tonifying kidney and strengthening yang the effect of,
Confirm that there are good antifatigue and yang invigorating functions through zoopery and clinical practice.The present invention is according to Chinese medicine compatibility theory in
Doctor trained in Western medicine combines theory and is configured to compound preparation, and using the black tiger palm and black pine as primary raw material, the two collaboration plays significant function
Activity can be learned, and greatly reduces cost of material, is conducive to industrialized production.Therefore, it from pharmaceutical formulation, preparation method and its answers
It is to report for the first time both at home and abroad from the point of view of range.
Specific embodiment
Below with reference to embodiment, the invention will be further described.Examples are merely exemplary for these, not to this hair
Bright range constitutes any restrictions.It will be understood by those skilled in the art that without departing from the spirit and scope of the invention
Can with the details and forms of the technical scheme of the invention are modified or replaced, but these modification and replacement each fall within it is of the invention
In protection scope.
HEIHUZHANG fungus used in embodiment and comparative example is be purchased from the deep Li Da Food Co., Ltd of Dongzhou Period in Chuxiong black
Albatrellus dispansus (Lloyd) Canf. & Gilb fructification.It is brownish-yellow powder through the smashed bacterium powder of pulverizer.
Black pine bacterium used in embodiment and comparative example is be purchased from the deep Li Da Food Co., Ltd of Dongzhou Period in Chuxiong black
Truffle mushroom entity.It is dark brown powder through the smashed bacterium powder of pulverizer.
Embodiment 1:
A kind of raw material composition with antifatigue and Yang strengthening function composition of the present embodiment are as follows:
HEIHUZHANG fungus powder 60g, black pine bacterium powder 40g.
The preparation method of the composition, comprising the following steps:
1, by HEIHUZHANG fungus and black pine bacterium it is dry after, crushed through pulverizer, cross 80 meshes, respectively obtain HEIHUZHANG fungus powder and black
Truffle bacterium powder.
2, the HEIHUZHANG fungus powder and black pine bacterium powder of selected parts by weight are taken, is uniformly mixed, the one kind for obtaining embodiment 1 has
The composition of antifatigue effect and Yang strengthening function.
Embodiment 2
Powder is prepared into antifatigue and Yang strengthening function composition by a kind of made from embodiment 1, the method is as follows:
(1) Example 1 is a kind of with antifatigue and Yang strengthening function composition 30g, adds water to cook 2 times, and 2 hours every time,
The quality that water is added every time is 10 times of composition quality, obtains decoction liquor；
(2) decoction liquor is merged, is filtered, after reduced pressure, spray-dried at powder, the one kind for obtaining embodiment 2, which has, to be resisted
The powder of fatigue and Yang strengthening function.
Embodiment 3:
Powder is prepared into antifatigue and Yang strengthening function composition by a kind of made from embodiment 1, the method is as follows:
By embodiment 1 it is a kind of have with antifatigue and Yang strengthening function composition and one kind made from embodiment 2 it is antifatigue
It is uniformly mixed with the powder 1:1 in mass ratio of Yang strengthening function, obtains a kind of of embodiment 3 and dissipated with antifatigue and Yang strengthening function
Agent.
Embodiment 4:
It is prepared as follows a kind of tablet with antifatigue and Yang strengthening function composition:
(1) it by after 30g HEIHUZHANG fungus and the drying of 55g black pine bacterium, is crushed through pulverizer, crosses 80 meshes, respectively obtain the black tiger palm
The composition of bacterium powder and black pine bacterium powder；
(2) the composition 50g for taking step (1) to obtain is added water to cook 2 times, and 2 hours every time, the quality that water is added every time was combination
10 times of amount of substance, obtain decoction liquor；
(3) decoction liquor is merged, is filtered, it is spray-dried at powder after reduced pressure；
(4) tablet is added in the powder obtained to step (3) and often uses auxiliary material, be uniformly mixed, be made by tablet common process various
Tablet.
Embodiment 5:
It is prepared as follows a kind of granule with antifatigue and Yang strengthening function composition:
(1) it by after 40g HEIHUZHANG fungus and the drying of 40g black pine bacterium, is crushed through pulverizer, crosses 80 meshes, respectively obtain the black tiger palm
The composition of bacterium powder and black pine bacterium powder；
(2) the composition 70g for taking step (1) to obtain is added water to cook 2 times, and 2 hours every time, the quality that water is added every time was combination
10 times of amount of substance, obtain decoction liquor；
(3) decoction liquor is merged, is filtered, it is spray-dried at powder after reduced pressure；
(4) granule is added in the powder obtained to step (3) and often uses auxiliary material, be uniformly mixed, be made by granule common process
Granule.
Embodiment 6:
It is prepared as follows a kind of pill with antifatigue and Yang strengthening function composition:
(1) it by after 50g HEIHUZHANG fungus and the drying of 30g black pine bacterium, is crushed through pulverizer, crosses 80 meshes, respectively obtain the black tiger palm
The composition of bacterium powder and black pine bacterium powder；
(2) the composition 70g for taking step (1) to obtain is added water to cook 2 times, and 2 hours every time, the quality that water is added every time was combination
10 times of amount of substance, obtain decoction liquor；
(3) decoction liquor is merged, is filtered, it is spray-dried at powder after reduced pressure；
(4) pill is added in the powder obtained to step (3) and often uses auxiliary material, be uniformly mixed, be made by pill common process various
Pill.
Embodiment 7:
It is prepared as follows a kind of capsule with antifatigue and Yang strengthening function composition:
(1) it by after 55g HEIHUZHANG fungus and the drying of 35g black pine bacterium, is crushed through pulverizer, crosses 80 meshes, respectively obtain the black tiger palm
The composition of bacterium powder and black pine bacterium powder；
(2) the composition 80g for taking step (1) to obtain is added water to cook 2 times, and 2 hours every time, the quality that water is added every time was combination
10 times of amount of substance, obtain decoction liquor；
(3) decoction liquor is merged, is filtered, it is spray-dried at powder after reduced pressure；
(4) capsule is added in the powder obtained to step (3) and often uses auxiliary material, be uniformly mixed, be made by capsule common process
Capsule.
Comparative example 1
HEIHUZHANG fungus powder, crushes through pulverizer, crosses 80 meshes.
Comparative example 2
Black pine bacterium powder, crushes through pulverizer, crosses 80 meshes.
Test case 1:
1 experimental animal, reagent and instrument
1.1 experimental animals: SPF grades of healthy Kunming strain male mices, weight 18-22 g are purchased from Jilin University experimental animal
The heart (credit number: SCXK (Jilin) 2017-0003).Use 12/12 hour illumination/dark cycle (8 points at night 8 of morning
The illumination of point) mouse to be raised in controlled environment (23 ± 1 DEG C of temperature, humidity 50 ± 10%), diet is free.
1.2 main agents: urea nitrogen (BUN), lactic acid (LA), lactic dehydrogenase (LDH), superoxide dismutase (SOD),
Glutathione peroxidase (GSH-Px), active oxygen (ROS), muscle glycogen and hepatic glycogen assay kit build up life purchased from Nanjing
Object Science and Technology Ltd.；Progesterone (PROG), testosterone (T) and estradiol (E2) ELISA assay kit are purchased from Shanghai source leaf biology
Science and Technology Ltd.；0.9% physiological saline is purchased from Jilin Cologne Cornell pharmaceutical Co. Ltd；BCA determination of protein concentration kit
It is purchased from Merck Millipore, Billerica, MA.
1.3 key instruments: microplate reader, SYNERGY4, the U.S. is rich to rise；96 orifice plates, NEST；Eddy mixer, OL-901, river
Haimen City kylin medical apparatus factory of Soviet Union；Electric drying oven with forced convection, 101A-1E, Shanghai laboratory apparatus Co., Ltd., Factory；Water bath with thermostatic control
Pot, GSY-II, Beijing Medical Equipment Plant；Supercentrifuge, Mini Spin, German Eppendorf；Animal treadmill, FT-
200, Chengdu TME Technology Co., Ltd.；Autonomic activities recorder, ZZ-6, Chengdu TME Technology Co., Ltd.；Tired transfer rod instrument,
ZB-200, Chengdu TME Technology Co., Ltd..
2 experimental methods
2.1 groupings and administration
SPF grades of healthy male Kunming strain mices 70, weight 18-22g, the dry feed of sawtooth class animal adapts to according to national standards
Property feed 5 days after, mouse is divided into 7 groups, every group 10 at random: being Normal group, (ginseng soap is dry for positive controls
Powder, wherein content of ginsenoside is 80%, is purchased from Xi'an all places Biotechnology Co., Ltd) 0.05 g/kg, example 1 group, reality
2 groups of example, 3 groups of embodiment, comparative example 1 and comparative example 2 are applied, is prepared into 0.1 g/mL's with the preceding sodium carboxymethylcellulose with 0.5%
Suspension.Gastric infusion is carried out between the daily 9:00-10:00 period, stomach-filling volume is 0.2 mL/20g, Normal group
It fills with isometric solvent, continuous gavage 14 days.With reference to the Ministry of Public Health " health food is examined and assessment technique specification " (version in 2003)
The middle function of physical fatigue alleviation method of inspection carries out the measurement of every antifatigue index after experiment.
The test of 2.2 autonomic activities
Mouse after each group stomach-filling is placed in quiet shady place, 30 minutes is stood, is put into autonomic activities case, covers and be protected from light plate, make
After mouse adapts to 2 min, standing number and action number in record mouse 5 minutes, parallel 3 times.
2.3 tired transfer rod tests
After last gastric infusion 30 minutes, each group mouse is individually placed in transfer rod instrument (15 revs/min), its muscle is made to be in quiet
Power tense situation.Before each group mouse is tested, suitably train, after mouse falls 3 times on transfer rod, start recording is small
The time that mouse is fallen from transfer rod due to muscular fatigue, parallel 3 times.
2.4 endurance run test
After last gastric infusion 30 minutes, mouse is placed in FT-200 animal treadmill, after placing animal, mouse is carried out
Instrument revolving speed is set as 20 revs/min after so that its understanding is fled from charging zone by training, and electric current is turned up full blast, and record mouse is electric
The time for hitting 5 times exhausts the time in this, as power.
2.5 swimming with a load attached to the body test
According to dosage design continuous gavage is administered 14 days, and after last gastric infusion 30 minutes, mouse is placed in water swimming, the depth of water
30 cm, 25 ± 1.0 DEG C of water temperature, the lead button of 10% weight of rat-tail root load, record mouse exhausts since swimming to power, as
The swimming time of mouse.Being sunk with mouse head can not float more than 8 s after water, and is placed on the plane and cannot complete to right
Reflection exhausts judgment criteria as power.
At once BUN, LA and LDH assay in serum after the swimming of 2.6 mouse
After successive administration 14 days, last stomach-filling mouse tested material 30 minutes, do not born in the water that temperature is 25 ± 0.5 DEG C
It swims 30 minutes when resetting.It takes out mouse to dry, orbital venous plexus takes 0.8 mL of blood immediately, and centrifugation prepares serum and is placed on -80
DEG C refrigerator saves.It is detected according to the measuring method of respective kit specification.
At once SOD, GSH-Px and ROS assay in serum after the swimming of 2.7 mouse
After successive administration 14 days, last stomach-filling mouse tested material 30 minutes, do not born in the water that temperature is 25 ± 0.5 DEG C
It swims 30 minutes when resetting.It takes out mouse to dry, orbital venous plexus takes 0.8 mL of blood immediately, and centrifugation prepares serum and is placed on -80
DEG C refrigerator saves.It is detected according to the measuring method of respective kit specification.
Muscle glycogen, hepatic glycogen content measurement after the swimming of 2.8 mouse
Mouse liver and hindlimb muscle are won immediately, are rejected connective tissue and superabundant fats, are frozen -80 DEG C of refrigerators, it is spare.According to
The measuring method of respective kit specification is detected.
2.9 statistical methods: SPSS16.0 handles data, and using one-way analysis of variance, P < 0.05 is judged as
Difference has conspicuousness, and P < 0.01 is judged as that difference has extremely significant property.
3 experimental results
The experiment of 3.1 autonomic activities
As shown in table 3.1, compared with Normal group, embodiment 1,2,3, positive controls and comparative example 1 and 2 groups pairs of comparative example
The action number and standing number of mouse do not have conspicuousness influence, illustrate the composition or preparation to the nervous centralis of mouse
System does not influence, and not will cause damage.
Influence of the table 3.1 to mouse autonomic activities
| Group | Number of animals/only | Action number | Standing number | P value |
| Normal group | 10 | 10.6±3.7 | 57.8±17.9 | |
| Positive controls | 10 | 11.1±5.1 | 60.9±19.0 | >0.05 |
| Embodiment 1 | 10 | 10.0±3.3 | 59.2±14.8 | >0.05 |
| Embodiment 2 | 10 | 10.4±5.9 | 60.2±15.3 | >0.05 |
| Embodiment 3 | 10 | 10.2±3.3 | 56.1±18.8 | >0.05 |
| Comparative example 1 | 10 | 10.3±4.8 | 57.3±17.3 | >0.05 |
| Comparative example 2 | 10 | 11.6±5.3 | 56.9±15.8 | >0.05 |
Note: P > 0.05, which is represented, does not have conspicuousness
3.2 tired turn-club tests
The raising of exercise tolerance is that anti-fatigue ability reinforces most strong macro manifestations, and transfer rod length of time can reflect animal fortune
Move the degree of fatigue.As shown in table 3.2, embodiment 1,2,3 and positive controls can significantly extend the transfer rod time of mouse,
It is respectively 1.2 times (P < 0.05) of Normal group mouse, 1.9 times (P < 0.01), 1.7 times (P < 0.05) and 1.1 times
(P < 0.05), comparative example 1 and 2 groups of comparative example it is not significant to the transfer rod time effects of mouse, do not show statistical significance.Phase
Compared with 1,2 and 3 group of embodiment, 2 groups of transfer rod times of comparative example 1 and comparative example be substantially less than composition of the invention (P <
0.05).
Influence of the table 3.2 to the mouse fatigue transfer rod time
| Group | Number of animals/only | The transfer rod time/s | P value |
| Normal group | 10 | 284.6±18.1 | |
| Positive controls | 10 | 322.9±14.7 | <0.05 |
| Embodiment 1 | 10 | 348.7±20.9 | <0.05 |
| Embodiment 2 | 10 | 530.4±27.5 | <0.01 |
| Embodiment 3 | 10 | 474.7±17.2 | <0.05 |
| Comparative example 1 | 10 | 318.3±15.8 | >0.05 |
| Comparative example 2 | 10 | 290.3±22.1 | >0.05 |
Note: P>0.05, which is represented, does not have conspicuousness, and P<0.05, which is represented, has conspicuousness, and P<0.01 represents extremely significant
3.3 endurance run experiment
If table 3.3 is shown, embodiment 1,2,3 and positive controls can significantly improve the running time of mouse, with normal control
Group is compared, and 14.8%(P < 0.05 has been respectively increased in the running time), 24.1%(P < 0.01), 30.0%(P < 0.01) and
35.4%(P < 0.01).Compared to 1 ~ 3 group of the embodiment of the present invention, the running time of 2 groups of extension mouse of comparative example 1 and comparative example
Significantly lower than composition (P < 0.05) of the invention, and 1 ~ 3 group of the embodiment of the present invention of endurance is run the time and is significantly higher than pair
The sum of ratio 1 and 2 group independent role.Wherein, 3 groups of effects of embodiment are best.
Table 3.3 runs the influence of time to Endurance
| Group | Number of animals/only | Run time/min | P value |
| Normal group | 10 | 23.7±4.8 | |
| Positive controls | 10 | 32.1±6.4 | <0.01 |
| Embodiment 1 | 10 | 27.2±4.2 | <0.05 |
| Embodiment 2 | 10 | 29.4±4.9 | <0.01 |
| Embodiment 3 | 10 | 30.8±7.5 | <0.01 |
| Comparative example 1 | 10 | 25.3±7.1 | >0.05 |
| Comparative example 2 | 10 | 24.9±6.2 | >0.05 |
Note: P>0.05, which is represented, does not have conspicuousness, and P<0.05, which is represented, has conspicuousness, and P<0.01 represents extremely significant
3.4 swimming with a load attached to the body experiment
Such as table 3.4,1 ~ 3 group of embodiment and positive controls can significantly extend the mice burden swimming time as the result is shown, compared with
Normal group is compared, and 17.2%(P < 0.05 has been respectively increased in swimming time), 20.7%(P < 0.05), 41.0%(P <
0.01) and 35.5%(P < 0.01), increased although the power of comparative example 1 and 2 group mouse exhausts the time, be significantly lower than this hair
1 ~ 3 group of bright embodiment, and 3 groups of influences of embodiment are extremely significant (P < 0.01), than 2 groups of independent roles of comparative example 1 and comparative example it
With improve 34.0%(P < 0.01).
Influence of the table 3.4 to mouse swimming time
| Group | Number of animals/only | Power exhausts the time/s | P value |
| Normal group | 10 | 358.6±80.1 | |
| Positive controls | 10 | 485.8±63.9 | <0.01 |
| Embodiment 1 | 10 | 420.3±56.3 | <0.05 |
| Embodiment 2 | 10 | 432.7±54.1 | <0.05 |
| Embodiment 3 | 10 | 505.7±70.8 | <0.01 |
| Comparative example 1 | 10 | 382.1±66.3 | >0.05 |
| Comparative example 2 | 10 | 370.2±55.6 | >0.05 |
Note: P>0.05, which is represented, does not have conspicuousness, and P<0.05, which is represented, has conspicuousness, and P<0.01 represents extremely significant
The influence of 3.5 compositions or preparation to BUN, LD and LDH in mice serum after swimming
Body BUN content increases with the increase of exercise load, and body is poorer to load performance, and the increase of BUN is brighter
It is aobvious.As shown in table 3.5, compared with Normal group, embodiment 1, embodiment 2 and comparative example 1 can be significantly reduced mouse trip
BUN content in serum, reduces 23.7%(P < 0.05 respectively after swimming), 28.8%(P < 0.01) and 18.7%(P < 0.05),
Embodiment 3 and positive controls effect are the most significant, reduce 30.9%(P < 0.001 than Normal group) and 33.8%(P <
0.001)；LA removing accretion rate is faster, and aerobic capacity is higher, is conducive to the rapid elimination of fatigue.With Normal group
It compares, embodiment 1, embodiment 2 and embodiment 3 can significantly reduce after mouse swimming LA content in serum, reduce respectively
17.6% (P < 0.05), 14.7% (P < 0.05) and 18.4%(P < 0.01), comparative example 1 and 2 does not show statistics meaning
Justice；LDH can reduce accumulation of the LA in muscle after movement.The elimination of LA depends on the catalytic action of LDH after movement, and LDH is living
Property increase, excessive LA in muscle can be accelerated to be changed into pyruvic acid, thus the generation of delay fatigue.Compared with Normal group,
Embodiment 2, embodiment 3 and positive controls can significantly improve the content of LDH in serum after mouse is swum, be respectively increased
4.7%(P<0.05), 6.7%(P<0.05) and 7.0%(P<0.05), comparative example 1 and 2 influences not significant (P>0.05),
Wherein, the influence of LDH activity becomes apparent in embodiment 2 and 3 pair mice serum.
Influence of the table 3.5 to BUN, LA and LDH content in mice serum
Note: compared with Normal group, P < 0.001 * P < 0.05, * * P < 0.01, * * *
The influence of 3.6 compositions or preparation to SOD, GSH-Px and ROS content in mice serum after swimming
SOD is to the most important antioxidase of antioxidant radical in organism, is the important indicator of measurement antioxidant ability of organism,
Body damage as caused by oxidative stress can be prevented, plays vital work in the oxidative and anti-oxidative balance of body
With.GSH-Px can promote H2O2Decomposition, protect the structure and function of cell membrane not by the interference of peroxide and damage.Such as
Shown in table 3.6,1 ~ 3 group of embodiment and positive controls can significantly improve after swimming that SOD is horizontal in mice serum, and normal right
Compared according to group, 25.6%(P < 0.05 be respectively increased), 28.6%(P < 0.01), 32.1%(P < 0.01) and 20.0%(P <
0.05)；Embodiment 2, embodiment 3 and positive controls significantly improve after swimming GSH-Px content in mice serum, and normal
Control group is compared, and 28.9%(P < 0.05 has been respectively increased), 33.7%(P < 0.01) and 35.9%(P < 0.01)；Embodiment
1,2,3, positive controls and comparative example 1 can be significantly reduced after swimming that ROS is horizontal in mice serum.In summary experiment hair
Existing, the antioxidant activity that 1 ~ 3 group of embodiment is better than comparative example 1 and 2 groups of comparative example, and wherein 3 groups of embodiment of influence is more significant,
Effect is best, shows that the present composition or preparation can be significantly improved in the case where HEIHUZHANG fungus and black pine Cordycepps learn compatibility effect
The oxidation resistance of mouse after swimming, synergistic effect are greater than the sum of two kinds of raw material independent roles.
Influence of the table 3.6 to mice serum SOD, GSH-Px and ROS level
Note: compared with Normal group, P < 0.01 * P < 0.05, * *
The influence of 3.7 compositions or preparation to mouse muscle glycogen, hepatic glycogen level after swimming
The endurance when storage level and movement of muscle glycogen is positively correlated, and muscle glycogen deposit is more, and energy supply is more sufficient, and endurance is just
Better；It is tired to can be used as resisting for evaluation body for maintaining blood glucose level important in inhibiting when moving for the deposit of hepatic glycogen
Labor index.As shown in table 3.7, compared with Normal group, 1 ~ 3 group of embodiment can improve mouse muscle glycogen and glycogen after swimming
Raw water is flat, and effect, better than the sum of 2 groups of independent roles of comparative example 1 and comparative example, wherein 55.7%(P has been respectively increased in embodiment 3
< 0.01) and 24.3%(P < 0.05).
Influence of the table 3.7 to mouse muscle glycogen and hepatic glycogen level
Note: compared with Normal group, P < 0.01 * P < 0.05, * *
The influence of 3.8 compositions or preparation to PROG, T and E2 level in mice serum after swimming
Influence of the table 3.8 to three kinds of sex hormone levels in mice serum
Note: compared with Normal group, P < 0.01 * P < 0.05, * *
Testosterone can promote androgone continuously to break up, and stimulate the generation and maturation of sperm, and promote reproductive development, protein
Synthesis and the growth of bone.As shown in table 3.8, compared with Normal group mouse, embodiment 1 ~ 3 improves male mice serum
Middle PROG and T is horizontal, and wherein 3 effect of embodiment is most significant (P < 0.05), and 1 ~ 3 group of embodiment of promotion effect is obviously excellent
In comparative example 1 and 2 groups of comparative example, prompt the present composition or preparation can by stimulating the secretion and synthesis of male sex hormone,
Promote the growth and development of sexual organ indirectly.T content in serum can be reduced, the present composition with the gradually aging at age
Or this effect of preparation, especially embodiment 3 will be helpful to delay the aging of sexual organ, so that it is strong to play anti-aging and production of sperm
The effect of positive.
Experimental example 1
The composition or preparation that above-described embodiment 1 ~ 3 is obtained carry out toxicologic study.
1 acute toxicity test (uses MTD method)
1.1 experimental animal；SPF Kunming mice, 40, weight 18-22g, half male and half female is purchased from Jilin University experimental animal
Center (credit number: SCXK(is lucky) 2017-0001).Experimental animal use is carried out in accordance with experimental animal using regulations, and animal is raised
It supports and guarantees 12h/12h Dark-light cycle, temperature is 23 ± 1 DEG C, humidity 50 ± 10%, free diet, drinking-water.
1.2 drugs and reagent: composition or preparation prepared by Example 1,2,3, with 0.5% carboxymethyl fibre before experiment
It ties up plain sodium and is dissolved to 0.2 g/mL drug concentration.
1.3 methods and result: each stomach-filling amount is 0.6 ml/, gives tested material one at interval of 6 hours using in one day
Secondary, twice, 16 h of mouse fasting (can't help water), oral stomach-filling are given tested material 3 days, are observed continuously after administration before stomach-filling for stomach-filling altogether
14 days.Dead and abnormal phenomenon does not occur for conventinal breeding in 14 days after mouse administration.Prove the embodiment 1 ~ 3 that the present invention obtains
Composition or preparation have no toxic side effect, and can use safely.
2 long term toxicity tests
2.1 experimental animals: Wistar rat, 120, weight 180-220g, half male and half female, purchased from Jilin University experimental animal
The heart (credit number: SCXK(is lucky) 2016-0003).
2.2 drugs and reagent: preparation prepared by Example 3 is dissolved with 0.5% sodium carboxymethylcellulose when experiment.
2.3 groupings and medication: experimental animal is randomly divided into 4 groups, every group 30 by gender weight.1 group of stomach-filling is given
0.5% sodium carboxymethylcellulose, 0.2 ml/100g；2, test medicine is given in 3,4 groups of stomach-fillings, dosage be respectively as follows: 25 mg/100g,
50 mg/100g, 100 mg/100g, i.e., every 100 g weight give the crude drug amount of 25 mg, 50 mg or 100 mg, each group concentration
It is each configured to the given low of 0.2 ml/100g.The above each group is euthanized after continuously taking 6 months.
2.4 Indexs measure
2.4.1 general status detects: weight, diet, mood, movable energy.
2.4.2 biochemical index: red blood cell count(RBC), white blood cell count(WBC), platelet count, hemoglobin count, serum
Albumen, cholesterol and blood glucose etc..
2.4.3 pathological examination: the heart, liver, spleen, lung, kidney, brain, stomach, thymus gland, sexual gland etc..
2.5 the experimental results showed that, after rat continuously takes 6 months 3 preparations of embodiment, weight, diet, mood, movable energy
The general status such as amount are good, each main organs and Serum Indexes no abnormality seen, it was demonstrated that 3 preparation of embodiment is to body without obvious long-term
Toxic effect.
Experimental example 2
The present composition or preparation are subjected to clinical human's test
1. sample and grouping
1.1 samples: the powder of the composition of embodiment 1, comparative example 1, comparative example 2 and embodiment 2 ~ 3 is subjected to tabletting respectively, respectively
1200, tablet is made, separately takes placebo 1200 made of starch.By HEIHUZHANG fungus powder and black pine bacterium powder in prescription ratio
It is uniformly mixed, the magnesium stearate that 0.25% ratio is added, which is uniformly mixed, is pressed into 1200 to get tablet.
1.2 methods: all volunteers are randomly divided into 6 groups, every group of 12 people, wherein 3 groups take above-mentioned 3 embodiments respectively
Sample tablet, 2 groups take the tablet of 2 sample of comparative example 1 and comparative example respectively, 0.6 g/ piece, one at a time, 3 times a day.
Separately there is one group of 12 people, takes orally the placebo of equivalent.Continuously take surrounding.
2. test method
2.1 sports equipments: Spinning
2.2 exercise tests: subject carries out the measurement of Spinning breakdown test, when scrunching before taking sample, after taking four weeks
Between be set as 5min, scrunch load be 5 grades, measure stepping movement before and after blood lactase acid value.And blood is detected when taking end of a period
The case where uric acid.
3. experimental result
3.1 subject's distribution situations
1 subject age of table and gender analysis
| Group | Number | Male | Female | Average age |
| Embodiment 1 | 12 | 6 | 6 | 30.2±1.9 |
| Embodiment 2 | 12 | 4 | 8 | 33.6±2.6 |
| Embodiment 3 | 12 | 5 | 7 | 32.5±2.2 |
| Comparative example 1 | 12 | 6 | 6 | 31.2±2.6 |
| Comparative example 2 | 12 | 5 | 7 | 32.3±2.0 |
| Placebo | 12 | 7 | 5 | 33.8±1.9 |
The result shows that between 3 embodiment groups, 2 comparative example groups and placebo group Sex distribution and men and women's age without obvious poor
It is different.
3.2 take blood uric acid value situation after four weeks
2 subject of table takes blood uric acid value (μm ol/L) after four weeks
| Group | Male | Women |
| Embodiment 1 | 364.0±79.5 | 220.8±54.2 |
| Embodiment 2 | 373.8±82.3 | 256.1±58.7 |
| Embodiment 3 | 377.2±68.6 | 237.5±66.0 |
| Comparative example 1 | 380.6±59.6 | 251.5±45.2 |
| Comparative example 2 | 379.5±62.8 | 232.8±39.7 |
| Placebo | 385.8±90.0 | 248.4±56.9 |
The result shows that the lower 3 embodiment groups of Different Preparation, 2 comparative example groups are taken compared with placebo, blood after four weeks
Uric acid level no significant difference shows that the present composition or preparation will not cause internal uric acid metabolism to be lacked of proper care.
The difference of measurement blood lactase acid, the lift-off value as blood lactase acid after exercise load before and after 3.3 subject's stepping movements.
3 subject's blood lactase acid of table, which increases, changes situation (mmol/L)
| Group | Blood lactase acid lift-off value before testing | Blood lactase acid lift-off value after experiment | Blood lactase acid increases change value |
| Embodiment 1 | 7.5±2.6 | 7.1±1.9 | -0.4±1.1 |
| Embodiment 2 | 7.9±1.8 | 7.6±2.4 | -0.3±1.8 |
| Embodiment 3 | 8.0±2.2 | 7.4±1.9 | -0.6±1.2 |
| Comparative example 1 | 7.7±1.6 | 7.6±1.8 | -0.1±1.5 |
| Comparative example 2 | 7.5±1.5 | 7.6±2.1 | 0.1±0.8 |
| Placebo | 7.6±3.0 | 7.7±2.8 | 0.1±0.9 |
Experimental result is shown, compared with placebo, subject is can be significantly reduced in the present composition for taking different formulations
The raising of blood lactase acid value after movement, increases the anti-fatigue ability of body, wherein blood cream after 1 ~ 3 group of reduction subject motion of embodiment
The degree of acid value is apparently higher than comparative example 1 and 2 groups of comparative example (P < 0.05), and 3 effect of embodiment is best.
The resistance to experiment of machanics of animal and physiological and biochemical index are the results show that the present composition or preparation can significantly extend
The endurance of mouse runs time, transfer rod time and walking weight load, and SOD, GSH-Px and LDH contain in mice serum after raising swimming
Amount reduces BUN, LA and ROS level in serum, increases the storage level of hepatic glycogen and muscle glycogen, prompts the present composition or system
Agent, which has, adjusts human body energy metabolism and preferable oxidation resistance.According to the Ministry of Public Health promulgate China " health food examine with
Assessment technique specification " 2003 years versions regulation, if more than one is tested (swimming with a load attached to the body and pole-climbing) and two containing an endurance exercise
Or more biochemistry containing binomial to be designated as positive (blood lactase acid, serum urea nitrogen, muscle glycogen hepatic glycogen etc.) be with antifatigue effect
Criterion.Meanwhile clinical human's test result is shown, the present composition or preparation can significantly reduce human body blood after movement
Lactate level.Moreover it is possible to remarkably promote the secretion of T and PROG in male mice serum, improve male's sexual defect indirectly.
Disclosure of the invention will be the new selection of one kind that the infull patient of male's sexual finds safe and effective therapeutic agent.To sum up
It is described, the present composition or preparation realized after HEIHUZHANG fungus and black pine Cordycepps learn composition of prescription exercise tolerance promoted,
It relieves fatigue, is anti-oxidant, delaying senescence, the effect of strengthening yang and invigorating kidney, the synergistic effect shown, not only drug activity shows excellent,
It is also greatly reduced cost of material, is conducive to industrialized production, is particularly suitable for the male of fatigue crowd and kidney yang virtual loss and early ageing
It takes.
Claims (5)
1. a kind of with antifatigue and Yang strengthening function composition, it is characterised in that be composed of the following raw materials in parts by weight: black tiger
30-85 parts of bacterium powder of the palm, 25-55 parts of black pine bacterium powder.
2. as described in claim 1 a kind of with antifatigue and Yang strengthening function composition, it is characterised in that by following weight
The raw material composition of part: 45-65 parts of HEIHUZHANG fungus powder, 35-45 parts of black pine bacterium powder.
3. as described in claim 1 a kind of with antifatigue and Yang strengthening function composition, it is characterised in that by following weight
The raw material composition of part: 60 parts of HEIHUZHANG fungus powder, 40 parts of black pine bacterium powder.
4. a kind of preparation method with antifatigue and Yang strengthening function composition as claimed in any one of claims 1-3,
It is characterized by:
(1) above-mentioned raw materials are weighed in proportion, are added water to cook 1-3 times, and 1-3 hours each, the quality that water is added every time is composition
8-12 times of quality, obtains decoction liquor；
(2) decoction liquor is merged, filter, after reduced pressure, it is spray-dried at powder to get.
5. it is as claimed in any one of claims 1-3 a kind of with antifatigue and Yang strengthening function composition, medicine can be made
Powder, oral solution, granule, tablet, capsule, pill, syrup or paste in object.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811167554.5A CN109157548B (en) | 2018-10-08 | 2018-10-08 | Composition with functions of resisting fatigue and tonifying yang and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811167554.5A CN109157548B (en) | 2018-10-08 | 2018-10-08 | Composition with functions of resisting fatigue and tonifying yang and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109157548A true CN109157548A (en) | 2019-01-08 |
| CN109157548B CN109157548B (en) | 2021-09-24 |
Family
ID=64877451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811167554.5A Active CN109157548B (en) | 2018-10-08 | 2018-10-08 | Composition with functions of resisting fatigue and tonifying yang and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109157548B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111458447A (en) * | 2020-05-11 | 2020-07-28 | 贵州中医药大学 | Chinese wolfberry quality detection method based on spectral efficiency relationship |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103340957A (en) * | 2013-06-28 | 2013-10-09 | 苏州菩芸生物科技有限公司 | Chinese herbal medicine compound for resisting fatigue of human body, nourishing kidneys and tonifying yang |
| CN104187592A (en) * | 2014-07-29 | 2014-12-10 | 北京上尚品生物科技有限公司 | Truffle slices and preparation method thereof |
-
2018
- 2018-10-08 CN CN201811167554.5A patent/CN109157548B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103340957A (en) * | 2013-06-28 | 2013-10-09 | 苏州菩芸生物科技有限公司 | Chinese herbal medicine compound for resisting fatigue of human body, nourishing kidneys and tonifying yang |
| CN104187592A (en) * | 2014-07-29 | 2014-12-10 | 北京上尚品生物科技有限公司 | Truffle slices and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| JIANG ET AL.: "The anti-fatigue activities of Tuber melanosporum in a mouse model", 《EXPERIMENTAL AND THERAPEUTIC MEDICINE》 * |
| XUE WANG ET AL.: "Antifatigue Potential Activity of Sarcodon imbricatus in Acute Excise-Treatd and Chronic Fatigue Syndrome in Mice via Regulation of Nrf2-Mediated Oxidative Stress", 《OXIDATIVE MEDICINE AND CELLULAR LONGEVITY》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111458447A (en) * | 2020-05-11 | 2020-07-28 | 贵州中医药大学 | Chinese wolfberry quality detection method based on spectral efficiency relationship |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109157548B (en) | 2021-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6873517B2 (en) | Health-maintaining product composition applicable to adult women, the elderly and people in sub-health conditions | |
| CN107691952A (en) | A kind of resisting kinetic fatigue, the composition for promoting postexercise recovery and preparation method thereof | |
| CN106244371B (en) | A kind of hypoglycemic rhizoma polygonati grape health care wine and its production technology | |
| CN102120953B (en) | Nutrient dry red health wine capable of preserving health and application thereof | |
| CN107455625A (en) | A kind of nutrient for plants beverage and its preparation technology with antifatigue weight losing function | |
| KR101771695B1 (en) | Pharmaceutical composition for the prevention and treatment of obesity comprising Spirulina maxima as an active ingredient | |
| CN100475254C (en) | Anti-fatigue resistibility capsules for improving body immunity and method for making same | |
| CN109997996A (en) | A kind of functional beverage of anti-senility and preparation method thereof | |
| CN102008083B (en) | Health food for alleviating physical fatigue and removing chloasma | |
| CN107890473A (en) | A kind of composition with fatigue-relieving and Yang strengthening function | |
| CN107912773A (en) | A kind of preparation for being used to alleviate physical fatigue | |
| CN109157548A (en) | It is a kind of with antifatigue and Yang strengthening function composition and preparation method | |
| CN106579392A (en) | Composition for alleviating delayed onset muscle soreness | |
| CN101804083B (en) | Application of pollen pini and extract thereof in treating inflammatory bowel disease and method for preparing extract | |
| CN101336705B (en) | Health food and its preparation method | |
| CN101129514A (en) | Fat-benefiting health care composition capsule and its preparing method | |
| CN105166896B (en) | A kind of health food of auxiliary improvement of memory power | |
| CN109394802A (en) | Herba Cynomorii extract is preparing the application in anti-fatigue medicament | |
| CN103845581A (en) | Natural green composition and application thereof to preventing and treating diabetes | |
| CN115211562B (en) | Traditional Chinese medicine flower gel composition for maintaining beauty and keeping young and preparation method thereof | |
| CN106108016A (en) | A kind of health food for relieving physical fatigue and preparation method thereof | |
| CN107242570A (en) | It is a kind of to improve the antifatigue health food of immunity | |
| CN102526370A (en) | Cordyceps preparation for promoting immunity of human body and preparation method thereof | |
| CN106692473A (en) | Compound herbal preparation capable of relieving physical fatigue and resisting oxidation and preparation method thereof | |
| CN108236714B (en) | Composition for relieving physical fatigue and assisting in reducing blood fat and soft capsule thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240403 Address after: No.13, 3rd floor, building 1, No.1, Tidu street, Qingyang District, Chengdu, Sichuan 610000 Patentee after: Chengdu yishenrui Technology Co.,Ltd. Country or region after: China Address before: No.2699, Qianjin Street, Changchun City, Jilin Province, 130011 Patentee before: Jilin University Country or region before: China |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240411 Address after: 130000 Old Village Department of Xinjia Village, Qianyugou East, Luxiang Township, Shuangyang District, Changchun City, Jilin Province Patentee after: Haiao Pharmaceutical (Changchun) Co.,Ltd. Country or region after: China Address before: No.13, 3rd floor, building 1, No.1, Tidu street, Qingyang District, Chengdu, Sichuan 610000 Patentee before: Chengdu yishenrui Technology Co.,Ltd. Country or region before: China |
|
| TR01 | Transfer of patent right |